CMF-00020 | LRP2 | up-regulates | IRF2 | activates | R-420 | 25 | 5 | Drugs (6) |
CMF-00023 | LRP2 | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-00526 | HMCN1 | up-regulates | IRF2 | activates | R-415 | 25 | 7 | Drugs (8) |
CMF-00527 | HMCN1 | up-regulates | IRF2 | activates | R-431 | 25 | 7 | Drugs (1) |
CMF-00528 | HMCN1 | up-regulates | IRF2 | activates | R-417 | 25 | 7 | Drugs (1) |
CMF-00529 | HMCN1 | up-regulates | IRF2 | activates | R-420 | 25 | 7 | Drugs (6) |
CMF-00530 | HMCN1 | up-regulates | IRF2 | activates | R-418 | 25 | 7 | Drugs (4) |
CMF-00531 | HMCN1 | up-regulates | IRF2 | activates | R-416 | 25 | 7 | Drugs (10) |
CMF-00532 | HMCN1 | up-regulates | IRF2 | activates | R-419 | 25 | 7 | Drugs (2) |
CMF-01849 | DAO | down-regulates | IRF2 | activates | R-420 | 25 | 1 | Drugs (6) |
CMF-04095 | JAG2 | up-regulates | IRF2 | activates | R-415 | 25 | 3 | Drugs (8) |
CMF-04096 | JAG2 | up-regulates | IRF2 | activates | R-418 | 25 | 3 | Drugs (4) |
CMF-05267 | PCSK6 | up-regulates | IRF2 | activates | R-417 | 25 | 1 | Drugs (1) |
CMF-06069 | FGFR3 | up-regulates | IRF2 | activates | R-413 | 25 | 3 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-06070 | FGFR3 | up-regulates | IRF2 | activates | R-416 | 25 | 3 | Drugs (10) |
CMF-06071 | FGFR3 | up-regulates | IRF2 | activates | R-419 | 25 | 3 | Drugs (2) |
CMF-06685 | ATRX | down-regulates | IRF2 | activates | R-415 | 25 | 14 | Drugs (8) |
CMF-06686 | ATRX | down-regulates | IRF2 | activates | R-431 | 25 | 14 | Drugs (1) |
CMF-06687 | ATRX | down-regulates | IRF2 | activates | R-417 | 25 | 14 | Drugs (1) |
CMF-06689 | ATRX | down-regulates | IRF2 | activates | R-420 | 25 | 14 | Drugs (6) |
CMF-06690 | ATRX | down-regulates | IRF2 | activates | R-426 | 25 | 14 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-06692 | ATRX | down-regulates | IRF2 | activates | R-418 | 25 | 14 | Drugs (4) |
CMF-06693 | ATRX | down-regulates | IRF2 | activates | R-416 | 25 | 14 | Drugs (10) |
CMF-06694 | ATRX | down-regulates | IRF2 | activates | R-419 | 25 | 14 | Drugs (2) |
CMF-06695 | ATRX | down-regulates | IRF2 | activates | R-424 | 25 | 14 | Drugs (4) |
CMF-07230 | NOD2 | up-regulates | IRF2 | activates | R-415 | 25 | 8 | Drugs (8) |
CMF-07231 | NOD2 | up-regulates | IRF2 | activates | R-431 | 25 | 8 | Drugs (1) |
CMF-07232 | NOD2 | up-regulates | IRF2 | activates | R-420 | 25 | 8 | Drugs (6) |
CMF-07233 | NOD2 | up-regulates | IRF2 | activates | R-418 | 25 | 8 | Drugs (4) |
CMF-07236 | NOD2 | up-regulates | IRF2 | activates | R-424 | 25 | 8 | Drugs (4) |
CMF-07658 | DPPA4 | up-regulates | IRF2 | activates | R-419 | 25 | 2 | Drugs (2) |
CMF-07705 | TRPM2 | up-regulates | IRF2 | activates | R-424 | 25 | 3 | Drugs (4) |
CMF-07871 | FAM83B | up-regulates | IRF2 | activates | R-424 | 25 | 2 | Drugs (4) |
CMF-08235 | KIF4A | down-regulates | IRF2 | activates | R-417 | 25 | 7 | Drugs (1) |
CMF-08236 | KIF4A | down-regulates | IRF2 | activates | R-420 | 25 | 7 | Drugs (6) |
CMF-08237 | KIF4A | down-regulates | IRF2 | activates | R-418 | 25 | 7 | Drugs (4) |
CMF-08239 | KIF4A | down-regulates | IRF2 | activates | R-413 | 25 | 7 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-08240 | KIF4A | down-regulates | IRF2 | activates | R-419 | 25 | 7 | Drugs (2) |
CMF-08241 | KIF4A | down-regulates | IRF2 | activates | R-424 | 25 | 7 | Drugs (4) |
CMF-09245 | RP1 | down-regulates | IRF2 | activates | R-420 | 25 | 4 | Drugs (6) |
CMF-09246 | RP1 | down-regulates | IRF2 | activates | R-418 | 25 | 4 | Drugs (4) |
CMF-11296 | RPTN | up-regulates | IRF2 | activates | R-426 | 25 | 2 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-11297 | RPTN | up-regulates | IRF2 | activates | R-416 | 25 | 2 | Drugs (10) |
CMF-12773 | ACACB | up-regulates | IRF2 | activates | R-418 | 25 | 4 | Drugs (4) |
CMF-12774 | ACACB | up-regulates | IRF2 | activates | R-416 | 25 | 4 | Drugs (10) |
CMF-12775 | ACACB | up-regulates | IRF2 | activates | R-419 | 25 | 4 | Drugs (2) |
CMF-13354 | FMN1 | up-regulates | IRF2 | activates | R-415 | 25 | 10 | Drugs (8) |
CMF-13357 | FMN1 | up-regulates | IRF2 | activates | R-426 | 25 | 10 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-14122 | CD1D | up-regulates | IRF2 | activates | R-431 | 25 | 3 | Drugs (1) |
CMF-14123 | CD1D | up-regulates | IRF2 | activates | R-426 | 25 | 3 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-14124 | CD1D | up-regulates | IRF2 | activates | R-424 | 25 | 3 | Drugs (4) |
CMF-15198 | OR51F1 | down-regulates | IRF2 | activates | R-413 | 25 | 5 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-15199 | OR51F1 | down-regulates | IRF2 | activates | R-416 | 25 | 5 | Drugs (10) |
CMF-15200 | OR51F1 | down-regulates | IRF2 | activates | R-419 | 25 | 5 | Drugs (2) |
CMF-15602 | DCHS2 | up-regulates | IRF2 | activates | R-431 | 25 | 5 | Drugs (1) |
CMF-15603 | DCHS2 | up-regulates | IRF2 | activates | R-426 | 25 | 5 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-15774 | GRM3 | up-regulates | IRF2 | activates | R-424 | 25 | 1 | Drugs (4) |
CMF-16893 | TIE1 | up-regulates | IRF2 | activates | R-431 | 25 | 3 | Drugs (1) |
CMF-16894 | TIE1 | up-regulates | IRF2 | activates | R-424 | 25 | 3 | Drugs (4) |
CMF-16995 | FLNA | down-regulates | IRF2 | activates | R-419 | 25 | 2 | Drugs (2) |
CMF-18168 | CDH19 | up-regulates | IRF2 | activates | R-417 | 25 | 6 | Drugs (1) |
CMF-18169 | CDH19 | up-regulates | IRF2 | activates | R-426 | 25 | 6 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-18278 | MEGF8 | up-regulates | IRF2 | activates | R-416 | 25 | 2 | Drugs (10) |
CMF-18279 | MEGF8 | up-regulates | IRF2 | activates | R-424 | 25 | 2 | Drugs (4) |
CMF-18363 | FANCM | down-regulates | IRF2 | activates | R-431 | 25 | 3 | Drugs (1) |
CMF-18365 | FANCM | down-regulates | IRF2 | activates | R-416 | 25 | 3 | Drugs (10) |
CMF-19052 | ST6GAL2 | down-regulates | IRF2 | activates | R-419 | 25 | 3 | Drugs (2) |
CMF-21158 | ADAM30 | up-regulates | IRF2 | activates | R-424 | 25 | 1 | Drugs (4) |
CMF-21246 | EGR1 | up-regulates | IRF2 | activates | R-431 | 25 | 1 | Drugs (1) |
CMF-21297 | GRIK3 | up-regulates | IRF2 | activates | R-415 | 25 | 9 | Drugs (8) |
CMF-21299 | GRIK3 | up-regulates | IRF2 | activates | R-426 | 25 | 9 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-21303 | GRIK3 | up-regulates | IRF2 | activates | R-416 | 25 | 9 | Drugs (10) |
CMF-21304 | GRIK3 | up-regulates | IRF2 | activates | R-424 | 25 | 9 | Drugs (4) |
CMF-21476 | POTEF | up-regulates | IRF2 | activates | R-431 | 25 | 3 | Drugs (1) |
CMF-21477 | POTEF | up-regulates | IRF2 | activates | R-416 | 25 | 3 | Drugs (10) |
CMF-22130 | PDGFRA | down-regulates | IRF2 | activates | R-431 | 25 | 3 | Drugs (1) |
CMF-22131 | PDGFRA | down-regulates | IRF2 | activates | R-420 | 25 | 3 | Drugs (6) |
CMF-22282 | IDH1 | down-regulates | IRF2 | activates | R-415 | 25 | 15 | Drugs (8) |
CMF-22283 | IDH1 | down-regulates | IRF2 | activates | R-431 | 25 | 15 | Drugs (1) |
CMF-22284 | IDH1 | down-regulates | IRF2 | activates | R-417 | 25 | 15 | Drugs (1) |
CMF-22286 | IDH1 | down-regulates | IRF2 | activates | R-420 | 25 | 15 | Drugs (6) |
CMF-22287 | IDH1 | down-regulates | IRF2 | activates | R-426 | 25 | 15 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-22290 | IDH1 | down-regulates | IRF2 | activates | R-418 | 25 | 15 | Drugs (4) |
CMF-22291 | IDH1 | down-regulates | IRF2 | activates | R-416 | 25 | 15 | Drugs (10) |
CMF-22292 | IDH1 | down-regulates | IRF2 | activates | R-419 | 25 | 15 | Drugs (2) |
CMF-22293 | IDH1 | down-regulates | IRF2 | activates | R-424 | 25 | 15 | Drugs (4) |
CMF-23158 | RNF17 | up-regulates | IRF2 | activates | R-426 | 25 | 4 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-23160 | RNF17 | up-regulates | IRF2 | activates | R-418 | 25 | 4 | Drugs (4) |
CMF-23161 | RNF17 | up-regulates | IRF2 | activates | R-416 | 25 | 4 | Drugs (10) |
CMF-23583 | TP53 | down-regulates | IRF2 | activates | R-415 | 25 | 15 | Drugs (8) |
CMF-23584 | TP53 | down-regulates | IRF2 | activates | R-431 | 25 | 15 | Drugs (1) |
CMF-23585 | TP53 | down-regulates | IRF2 | activates | R-417 | 25 | 15 | Drugs (1) |
CMF-23586 | TP53 | down-regulates | IRF2 | activates | R-420 | 25 | 15 | Drugs (6) |
CMF-23587 | TP53 | down-regulates | IRF2 | activates | R-426 | 25 | 15 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-23589 | TP53 | down-regulates | IRF2 | activates | R-418 | 25 | 15 | Drugs (4) |
CMF-23590 | TP53 | down-regulates | IRF2 | activates | R-413 | 25 | 15 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-23591 | TP53 | down-regulates | IRF2 | activates | R-416 | 25 | 15 | Drugs (10) |
CMF-23592 | TP53 | down-regulates | IRF2 | activates | R-419 | 25 | 15 | Drugs (2) |
CMF-23593 | TP53 | down-regulates | IRF2 | activates | R-424 | 25 | 15 | Drugs (4) |
CMF-24252 | SFRS15 | up-regulates | IRF2 | activates | R-416 | 25 | 2 | Drugs (10) |
CMF-24253 | SFRS15 | up-regulates | IRF2 | activates | R-424 | 25 | 2 | Drugs (4) |
CMF-24429 | SEMA3C | down-regulates | IRF2 | activates | R-415 | 25 | 7 | Drugs (8) |
CMF-24430 | SEMA3C | down-regulates | IRF2 | activates | R-431 | 25 | 7 | Drugs (1) |
CMF-24431 | SEMA3C | down-regulates | IRF2 | activates | R-426 | 25 | 7 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-24435 | SEMA3C | down-regulates | IRF2 | activates | R-424 | 25 | 7 | Drugs (4) |
CMF-24915 | NLRP1 | up-regulates | IRF2 | activates | R-431 | 25 | 7 | Drugs (1) |
CMF-24916 | NLRP1 | up-regulates | IRF2 | activates | R-426 | 25 | 7 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-24917 | NLRP1 | up-regulates | IRF2 | activates | R-413 | 25 | 7 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-24918 | NLRP1 | up-regulates | IRF2 | activates | R-416 | 25 | 7 | Drugs (10) |
CMF-24919 | NLRP1 | up-regulates | IRF2 | activates | R-419 | 25 | 7 | Drugs (2) |
CMF-26291 | CHGB | up-regulates | IRF2 | activates | R-431 | 25 | 4 | Drugs (1) |
CMF-26292 | CHGB | up-regulates | IRF2 | activates | R-426 | 25 | 4 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-26294 | CHGB | up-regulates | IRF2 | activates | R-424 | 25 | 4 | Drugs (4) |
CMF-26348 | CARM1 | down-regulates | IRF2 | activates | R-417 | 25 | 3 | Drugs (1) |
CMF-27489 | KRTAP20-2 | up-regulates | IRF2 | activates | R-431 | 25 | 5 | Drugs (1) |
CMF-27490 | KRTAP20-2 | up-regulates | IRF2 | activates | R-426 | 25 | 5 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-27492 | KRTAP20-2 | up-regulates | IRF2 | activates | R-413 | 25 | 5 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-30360 | CACNA1I | up-regulates | IRF2 | activates | R-420 | 25 | 3 | Drugs (6) |
CMF-31218 | SHP2_SIGNALING | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-31295 | CLASS_I_PI3K_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-413 | 25 | 4 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-31348 | ANGIOPOIETIN_RECEPTOR_TIE2_MEDIATED_SIGNALING | up-regulates | IRF2 | activates | R-417 | 25 | 7 | Drugs (1) |
CMF-31350 | ANGIOPOIETIN_RECEPTOR_TIE2_MEDIATED_SIGNALING | up-regulates | IRF2 | activates | R-424 | 25 | 7 | Drugs (4) |
CMF-31401 | IL3_MEDIATED_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-31433 | SIGNALING_EVENTS_MEDIATED_BY_TCPTP | up-regulates | IRF2 | activates | R-418 | 25 | 7 | Drugs (4) |
CMF-31434 | SIGNALING_EVENTS_MEDIATED_BY_TCPTP | up-regulates | IRF2 | activates | R-424 | 25 | 7 | Drugs (4) |
CMF-31500 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-417 | 25 | 9 | Drugs (1) |
CMF-31501 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-426 | 25 | 9 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-31503 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-424 | 25 | 9 | Drugs (4) |
CMF-31624 | PDGFR_BETA_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-413 | 25 | 6 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-31625 | PDGFR_BETA_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-31760 | ERBB4_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-31822 | EPHB_FORWARD_SIGNALING | up-regulates | IRF2 | activates | R-426 | 25 | 4 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-31973 | E_CADHERIN_SIGNALING_NASCENT_ADHERENS_JUNCTION | up-regulates | IRF2 | activates | R-424 | 25 | 4 | Drugs (4) |
CMF-32022 | SIGNALING_EVENTS_MEDIATED_BY_HEPATOCYTE_GFR | up-regulates | IRF2 | activates | R-417 | 25 | 7 | Drugs (1) |
CMF-32024 | SIGNALING_EVENTS_MEDIATED_BY_HEPATOCYTE_GFR | up-regulates | IRF2 | activates | R-424 | 25 | 7 | Drugs (4) |
CMF-32061 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | IRF2 | activates | R-417 | 25 | 10 | Drugs (1) |
CMF-32062 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | IRF2 | activates | R-426 | 25 | 10 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-32064 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | IRF2 | activates | R-418 | 25 | 10 | Drugs (4) |
CMF-32065 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | IRF2 | activates | R-424 | 25 | 10 | Drugs (4) |
CMF-32476 | CXCR4_MEDIATED_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-413 | 25 | 6 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-32477 | CXCR4_MEDIATED_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-32686 | NONGENOTROPIC_ANDROGEN_SIGNALING | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-32768 | E_CADHERIN_SIGNALING_IN_KERATINOCYTES | up-regulates | IRF2 | activates | R-417 | 25 | 8 | Drugs (1) |
CMF-32769 | E_CADHERIN_SIGNALING_IN_KERATINOCYTES | up-regulates | IRF2 | activates | R-426 | 25 | 8 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-32771 | E_CADHERIN_SIGNALING_IN_KERATINOCYTES | up-regulates | IRF2 | activates | R-424 | 25 | 8 | Drugs (4) |
CMF-32864 | EPHA2_FORWARD_SIGNALING | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-33101 | IL5_MEDIATED_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-33259 | IL2_SIGNALING_EVENTS_MEDIATED_BY_PI3K | up-regulates | IRF2 | activates | R-416 | 25 | 6 | Drugs (10) |
CMF-33260 | IL2_SIGNALING_EVENTS_MEDIATED_BY_PI3K | up-regulates | IRF2 | activates | R-424 | 25 | 6 | Drugs (4) |
CMF-33289 | ERBB1_DOWNSTREAM_SIGNALING | up-regulates | IRF2 | activates | R-417 | 25 | 8 | Drugs (1) |
CMF-33290 | ERBB1_DOWNSTREAM_SIGNALING | up-regulates | IRF2 | activates | R-426 | 25 | 8 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-33292 | ERBB1_DOWNSTREAM_SIGNALING | up-regulates | IRF2 | activates | R-424 | 25 | 8 | Drugs (4) |
CMF-33483 | NEPHRIN_NEPH1_SIGNALING_IN_THE_KIDNEY_PODOCYTE | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-33593 | ERBB2_ERBB3_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-33667 | BCR_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-413 | 25 | 5 | Drugs (139) Regulator Drugs (0)Regulon Drugs (139)PF-04691502, FOSTAMATINIB DISODIUM, PICOTAMIDE, UMBRALISIB, FIBOFLAPON SODIUM, ATN-161, BGT-226, SONOLISIB, CSL-324, TERBOGREL, PARSACLISIB, INTERFERON GAMMA-1B, R-343, VOXTALISIB, BMS-986142, HM-71224, NEMIRALISIB, RP-6530, BIIB-023, APITOLISIB, AME-133V, DASATINIB, DS-7423, GSK-2269557, L19IL2, INCB-40093, MSC-2364447, PAXALISIB, AS-1409, PICTILISIB, R-348, PF-06651600, AMY-101, LIPEGFILGRASTIM, ABIVERTINIB, VRC-01LS, ABIVERTINIB MALEATE, MEDI-2338, TG100-115, VS-5584, COPANLISIB, SAMOTOLISIB, VOBARILIZUMAB, CERDULATINIB, DUVELISIB, CAROTUXIMAB, L19TNFA, EFALIZUMAB, DACTOLISIB, BOSUTINIB, FILGRASTIM, ZANDELISIB, HMPL-523, TOCILIZUMAB, AZD-8186, GNF-Pf-5468, WX-037, RILZABRUTINIB, BALUGRASTIM, SPEBRUTINIB, PILARALISIB, ILORASERTIB, DAPANSUTRILE, RO-5458640, TASELISIB, L19SIP 131I, AMG-319, IBRUTINIB, TADEKINIG ALFA, COPANLISIB HYDROCHLORIDE, TENALISIB, PETESICATIB, SELETALISIB, PF-04605412, GEDATOLISIB, OMIPALISIB, SARILUMAB, UMBRALISIB TOSYLATE, NEIHULIZUMAB, IDELALISIB, ZANUBRUTINIB, XL-228, FIMEPINOSTAT, ENTOSPLETINIB, SATRALIZUMAB, EVOBRUTINIB, SELGANTOLIMOD, R-333, OTLERTUZUMAB, GUSACITINIB, BI-836826, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TG100-801, SPEBRUTINIB BESYLATE, PEGCETACOPLAN, LENOGRASTIM, POSELTINIB, LIFITEGRAST, VB-201, ACALISIB, ZANOLIMUMAB, MIVAVOTINIB CITRATE, VELIFLAPON, PIRTOBRUTINIB, TELRATOLIMOD, IBALIZUMAB, OCRIPLASMIN, CAL-263, UB-421, ACALABRUTINIB, ERITORAN, MILATUZUMAB, VOLOCIXIMAB, FOSTAMATINIB, TOMARALIMAB, ELSUBRUTINIB, BRANEBRUTINIB, LENIOLISIB, OZAGREL, PA-799, TIRABRUTINIB, FENEBRUTINIB, LEVILIMAB, GSK-1059615, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, BUPARLISIB, VESENCUMAB, NARATUXIMAB EMTANSINE, SF-1126, ORELABRUTINIB, GSK-1070806, FIBOFLAPON, AL-78898A, ENMD-981693, PANULISIB |
CMF-33668 | BCR_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-33706 | IL6_MEDIATED_SIGNALING_EVENTS | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-33743 | FGF_SIGNALING_PATHWAY | up-regulates | IRF2 | activates | R-424 | 25 | 5 | Drugs (4) |
CMF-33782 | SIGNALING_EVENTS_MEDIATED_BY_PTP1B | up-regulates | IRF2 | activates | R-426 | 25 | 5 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |